Release Time:2019-10-12 Hits:
First Author: 李文利
Disigner of the Invention: 张嘉宁,刘宇博,Yajun Liu,杜晓云
Application Number: CN201810375967.6
Authorization Date: 2018-04-20
Authorization Number: CN108651470A
Prev One:一种达卡巴嗪衍生物、制备方法及新用途
Next One:miR24‑1在抑制肿瘤细胞转移中的应用